A deal with FEI comes a couple months after Thermo Fisher defended its acquisition of Affymetrix ($AFFY). A shell company put up a last-minute takeover bid meant to derail the sale. But Thermo Fisher ultimately emerged victoriously and sealed its $1.3 billion deal for the gene editing firm. - here's the statement Special Reports: Med tech M&A gets much, much bigger during the first half - Thermo Fisher bought Life Technologies | The top 10 med tech M&A deals of 2013 - Thermo Fisher and Life Technologies